Last updated: March 2026
SNAP-8 (acetyl octapeptide-3) is a cosmetic peptide that reduces expression wrinkles by modulating the SNARE complex. Clinical studies show up to 63% wrinkle depth reduction around the eyes, outperforming its predecessor Argireline without injections.
SNAP-8 is an extension of Argireline (acetyl hexapeptide-8) with two additional amino acids. It mimics the N-terminal end of SNAP-25, a protein in the SNARE complex that mediates neurotransmitter release for muscle contraction. By competing for SNARE assembly, it softens expression lines topically.
Competes with SNAP-25 for position in the SNARE complex, reducing exocytosis of acetylcholine at the neuromuscular junction. This limits excessive muscle contractions that create expression lines.
Unlike botulinum toxin which cleaves SNARE proteins causing paralysis, SNAP-8 only modulates complex formation — reducing overactivity while preserving natural facial expression.
The two additional amino acids provide better SNARE complex binding affinity compared to the hexapeptide Argireline, resulting in enhanced wrinkle reduction in comparative studies.
Water-soluble peptide applied topically as a serum. Penetrates the stratum corneum to reach the dermis. No injections required — a key advantage over Botox.
Context: SNAP-8 was developed by Lipotec (now Lubrizol). The efficacy data comes primarily from manufacturer-sponsored clinical studies. Independent peer-reviewed data is more limited but supportive. Analytical methods have been validated in peer-reviewed journals.
Self-Assessment
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Third-party tested compounds from Swiss Chems — one of the most trusted research suppliers.
Affiliate link — supports MeetPeptide at no extra cost.
SNAP-8 is a cosmetic ingredient, not a drug. It is not FDA-evaluated for treating any medical condition. This page is for educational purposes only. Not medical advice. Cosmetic Ingredient